Home > > > > > Report Detail

Colorectal Cancer Diagnostic Market with Focus on DNA-Based Tests: Industry Analysis & Outlook (2018-2025)

Publisher Name :
Date: 23-Jul-2018
No. of pages: 86
Inquire Before Buying

Colorectal cancer, also known as bowel cancer and colon cancer, is the development of the cancer in the colon or rectum. A cancer is the abnormal growth of the cells that have the ability to invade or spread to the other parts of the body. Colorectal cancer begins when the healthy cells in the lining of the colon or rectum changes and grows out of control, forming a mass called tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread. These changes usually take years to develop.

Screening for colorectal cancer is effective not only for early detection but also for prevention. Diagnosis of colorectal cancer through screening tends to occur 2-3 years before diagnosis of cases with symptoms. CRC Screening is broadly divided into Structural Examination and Stool Tests. Structural examination is further divide into Flexible Sigmoidography, Colonoscopy and Computed Tomographic Colonography, whereas Stool Tests are divided into Occult blood and DNA tests.

Colorectal cancer diagnostic market is expected to grow in future due to increasing disposable income, increasing ageing population and cancer incidences and rising healthcare expenditure. Key trends of this market include launch of branded and advanced diagnosis and technology innovation. However, there are some factors which can hinder the market growth including stringent legal norms, high cost, need for high quality of screening process and dearth of expertise.

The report “Colorectal Cancer Diagnostics Market with Focus on DNA-based Tests: Industry Analysis & Outlook (2018-2025)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S., Europe and Asia. The report profiles the key players of the market including Epigenomics, Exact Sciences Corporation, VoilitionRx Ltd and Quest Diagnostics

Colorectal Cancer Diagnostic Market with Focus on DNA-Based Tests: Industry Analysis & Outlook (2018-2025)

Table of Contents

1. Introduction
1.1 Colorectal Cancer
1.2 Diagnosis
1.3 Treatment

2. Market Overview
2.1 Global Colorectal Cancer Incidences Forecast
2.2 CRC Death Averted per 1,000 Individuals Screened
2.3 Distribution of Colorectal Cases and Relative Survival
2.4 Colorectal Cancer Screening Test Types

3. The U.S. Colorectal Cancer Screening Market
3.1 The U.S. CRC Screening Eligible Patient Volume Forecast
3.2 The U.S. CRC Screening Receiving Patient Volume Forecast
3.3 The U.S. CRC Screening Test Market Volume Forecast
3.4 The U.S. CRC Screening Market Volume by Type
3.4.1 The U.S. CRC Colonoscopies Volume Forecast
3.4.2 The U.S. CRC Sigmoidoscopies Volume Forecast
3.4.3 The U.S. CRC FOBT Volume Forecast
3.4.4 The U.S. CRC Stool Based DNA Test Volume Forecast
3.5 The U.S. CRC Screening Test Product Market
3.5.1 The U.S. CRC Frontline Screening Tested Patient Volume Forecast
3.5.2 The U.S. CRC Frontline Screening Test Sales Forecast by Value
3.5.3 The U.S. CRC Cologuard Screening Test Sales Forecast
3.5.4 The U.S. CRC Epi proColon Screening Test Sales Value Forecast

4. Europe Colorectal Cancer Screening Market
4.1 Europe CRC Screening Eligible Patient Volume Forecast
4.2 Europe CRC Screening Eligible Patient Volume by Country
4.2.1 The UK CRC Screening Eligible Patient Volume Forecast
4.2.2 Sweden CRC Screening Eligible Patient Volume Forecast
4.2.3 Denmark CRC Screening Eligible Patient Volume Forecast
4.2.4 Netherland CRC Screening Eligible Patient Volume Forecast
4.3 Europe CRC Screening Receiving Patient Volume Forecast
4.4 Europe CRC Screening Test Product Market
4.4.1 Europe CRC Frontline Screening Tested Patient Volume Forecast
4.4.2 Europe CRC Frontline Screening Test Sales Forecast by Value
4.4.3 Europe CRC Triage Screening Tested Patient Volume Forecast
4.4.4 Europe CRC Triage Screening Test Sales Forecast by Value

5. Asia Colorectal Cancer Screening Market
5.1 Asia CRC Screening Eligible Patient Volume Forecast
5.2 Asia CRC Screening Test Product Market
5.2.1 Asia CRC Frontline Screening Tested Patient Volume Forecast
5.2.2 Asia CRC Frontline Screening Test Sales Forecast by Value
5.2.3 Asia CRC Triage Screening Test Sales Forecast by Value
5.2.4 Asia CRC Triage Screening Tested Patient Volume Forecast

6. Market Dynamics
6.1 Growth Drivers
6.1.1 Increasing Disposable Income
6.1.2 Acceleration of Ageing Population and Cancer Incident Cases
6.1.3 Rising Healthcare Expenditure
6.2 Key Trends
6.2.1 Launch of Branded and Advanced Diagnostic Tests
6.2.2 Technology Innovation
6.3 Challenges
6.3.1 Stringent Legal Norms
6.3.2 High Cost and Alternative Treatments
6.3.3 Need for High Quality of Screening Process
6.3.4 Dearth of Expertise

7. Competition
7.1 Global Market
7.1.1 Revenue Comparison of Key Players
7.1.3 DNA based CRC Screening Tests Comparison

8. Company Profiles
8.1 Exact Sciences Corporation
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategies
8.2 Volition Rx Ltd.
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategies
8.3 Epigenomics AG
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategies
8.4 Quest Diagnostics
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Business Strategies

List of Tables

CRC Death Averted per 1,000 Individuals Screened (2017)
Distribution of Colorectal Cancer Cases and Relative Survival
Types of Colorectal Cancer Screening Tests
Revenue Comparison of Key Players (2017)
DNA based CRC Screening Tests Comparison (2017)

List of Charts

Types of CRC Screening
Global Colorectal Cancer Incidences Forecast (2017-2022)
The U.S. CRC Screening Eligible Patient Volume Forecast (2018-2025)
The U.S. CRC Screening Receiving Patient Volume Forecast (2018-2025)
The U.S. CRC Screening Test Market Volume Forecast (2017-2022)
The U.S. CRC Screening Market Volume by Type (2017)
The U.S. CRC Colonoscopies Volume Forecast (2017-2022)
The U.S. CRC Sigmoidoscopies Volume Forecast (2017-2022)
The U.S. CRC FOBT Volume Forecast (2017-2022)
The U.S. CRC Stool Based DNA Test Volume Forecast (2017-2022)
The U.S. CRC Frontline Screening Tested Patient Volume Forecast (2021-2025)
The U.S. CRC Frontline Screening Test Sales Forecast by Value (2021-2025)
The U.S. CRC Cologuard Screening Test Sales forecast (2017-2022)
The U.S. CRC Epi proColon Screening Test Sales Value forecast (2017-2022)
Europe CRC Screening Eligible Patient Volume Forecast (2018-2025)
The UK CRC Screening Eligible Patient Volume Forecast (2018-2025)
Sweden CRC Screening Eligible Patient Volume Forecast (2018-2025)
Denmark CRC Screening Eligible Patient Volume Forecast (2018-2025)
Netherland CRC Screening Eligible Patient Volume Forecast (2018-2025)
Europe CRC Screening Receiving Patient Volume Forecast (2018-2025)
Europe CRC Frontline Screening Tested Patient Volume Forecast (2019-2025)
Europe CRC Frontline Screening Test Sales Forecast by Value (2019-2025)
Europe CRC Triage Screening Tested Patient Volume Forecast (2018-2025)
Europe CRC Triage Screening Test Sales Forecast by Value (2018-2025)
Asia CRC Screening Eligible Patient Volume Forecast (2018-2025)
Asia CRC Frontline Screening Tested Patient Volume Forecast (2019-2025)
Asia CRC Frontline Screening Test Sales Forecast by Value (2019-2015)
Asia CRC Triage Screening Test Sales Forecast by Value (2019-2025)
Asia CRC Triage Screening Tested Patient Volume Forecast (2019-2025)
Global GNI per Capita (2013-2017)
Global Ageing Population above 65 Years (2013-2017)
Global Healthcare Expenditure Per Capita (2013-2017)
Exact Sciences Corporation Sales and Net Earnings (2013-2017)
Exact Sciences Corporation Research and Development Expenditure (2015-2017)
Exact Sciences Corporation Media and Advertisement Expenditure (2015-2017)
Volition Rx Ltd. Net loss (2013-2017)
Volition Rx Ltd. Research and Development Expenditure (2015-2017)
Volition Rx Ltd. Media and Advertisement Expenditure (2016-2017)
Epigenomics Revenue by Segment (2017)
Epigenomics Revenue and Net Loss (2013-2017)
Epigenomics Research and Development Expenditure (2016-2017)
Quest Diagnostics Revenue by Segment (2017)
Quest Diagnostics Revenue and Net Income (2013-2017)

  • Global Prostate Cancer Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Prostate Cancer Diagnostics market size was valued at US$ 13140 million in 2023. With growing demand in downstream market, the Prostate Cancer Diagnostics is forecast to a readjusted size of US$ 22650 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global Prostate Cancer Diagnostics market. Prostate Cancer Diagnostics are expected to show stable growth in th......
  • Global Checkpoint Inhibitors for Treating Cancer Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 83
    According to our LPI (LP Information) latest study, the global Checkpoint Inhibitors for Treating Cancer market size was valued at US$ 12220 million in 2023. With growing demand in downstream market, the Checkpoint Inhibitors for Treating Cancer is forecast to a readjusted size of US$ 63530 million by 2030 with a CAGR of 26.6% during review period. The research report highlights the growth potential of the global Checkpoint Inhibitors for Treating Cancer market. Checkpoint Inhibitors for......
  • Global PSA Test Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 111
    According to our LPI (LP Information) latest study, the global PSA Test market size was valued at US$ 499.9 million in 2023. With growing demand in downstream market, the PSA Test is forecast to a readjusted size of US$ 861.8 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global PSA Test market. PSA Test are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global HPV Testing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87
    According to our LPI (LP Information) latest study, the global HPV Testing market size was valued at US$ 784.6 million in 2023. With growing demand in downstream market, the HPV Testing is forecast to a readjusted size of US$ 1398.7 million by 2030 with a CAGR of 8.6% during review period. The research report highlights the growth potential of the global HPV Testing market. HPV Testing are expected to show stable growth in the future market. However, product differentiation, reducing cos......
  • Global Prostate Cancer Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 102
    According to our (Global Info Research) latest study, the global Prostate Cancer Diagnostics market size was valued at USD 13820 million in 2023 and is forecast to a readjusted size of USD 22870 million by 2030 with a CAGR of 7.5% during review period. The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be ......
  • Global Pap Tests and HPV Tests Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 130
    The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......
  • Global Pap Tests and HPV Tests Professional Survey Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 3280 Onwards        Pages: 106
    The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......
  • Global Checkpoint Inhibitors For Treating Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Checkpoint Inhibitors For Treating Cancer market: According to our latest research, the global Checkpoint Inhibitors For Treating Cancer market looks promising in the next 5 years. As of 2022, the global Checkpoint Inhibitors For Treating Cancer market was estimated at USD 18595.4 million, and it's anticipated to reach USD 42557.61 million in 2028, with a CAGR of 14.8% during the forecast years. Checkpoint inhibitor is a type of drug used in immunoth......
  • Global Solid Tumor Testing Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 100
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs